Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley Jones

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Cell|February 26, 2022
Multiple early factors anticipate post-acute COVID-19 sequelaeYapeng Su, Dan Yuan, Daniel G Chen, et al.
Plos One|November 19, 2010
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseLesley Jones, Peter A Holmans, Marian L Hamshere, et al.
Journal of Alzheimer'S Disease : JAD|October 27, 2011
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's diseaseAmy Gerrish, Giancarlo Russo, Alexander Richards, et al.
Nature Genetics|April 5, 2011
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseasePaul Hollingworth, Denise Harold, Rebecca Sims, et al.
Plos One|June 13, 2014
Gene-wide analysis detects two new susceptibility genes for Alzheimer's diseaseValentina Escott-Price, Céline Bellenguez, Li-San Wang, et al.
Nature Genetics|August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|July 18, 2017
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's diseaseRebecca Sims, Sven J van der Lee, Adam C Naj, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Cell|February 26, 2022
Multiple early factors anticipate post-acute COVID-19 sequelaeYapeng Su, Dan Yuan, Daniel G Chen, et al.
Plos One|November 19, 2010
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseLesley Jones, Peter A Holmans, Marian L Hamshere, et al.
Journal of Alzheimer'S Disease : JAD|October 27, 2011
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's diseaseAmy Gerrish, Giancarlo Russo, Alexander Richards, et al.
Nature Genetics|April 5, 2011
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseasePaul Hollingworth, Denise Harold, Rebecca Sims, et al.
Plos One|June 13, 2014
Gene-wide analysis detects two new susceptibility genes for Alzheimer's diseaseValentina Escott-Price, Céline Bellenguez, Li-San Wang, et al.
Nature Genetics|August 17, 2019
Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|March 2, 2019
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processingBrian W Kunkle, Benjamin Grenier-Boley, Rebecca Sims, et al.
Nature Genetics|July 18, 2017
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's diseaseRebecca Sims, Sven J van der Lee, Adam C Naj, et al.
Pageof 14